Index by author
April 01, 2002; Volume 301,Issue 1
Gerken, Manfred
- You have accessDose Optimization of a Doxorubicin Prodrug (HMR 1826) in Isolated Perfused Human Lungs: Low Tumor pH Promotes Prodrug Activation by β-GlucuronidaseThomas E. Mürdter, Godehard Friedel, Janne T. Backman, Monika McClellan, Monika Schick, Manfred Gerken, Klaus Bosslet, Peter Fritz, Heikki Toomes, Heyo K. Kroemer and Bernhard SperkerJournal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 223-228; DOI: https://doi.org/10.1124/jpet.301.1.223
Germain, Noëlla
- You have accessThe Selective Phosphodiesterase 4 Inhibitor RP 73-401 Reduced Matrix Metalloproteinase 9 Activity and Transforming Growth Factor-β Release During Acute Lung Injury in Mice: The Role of the Balance Between Tumor Necrosis Factor-α and Interleukin-10Marianne Corbel, Noëlla Germain, Jérôme Lanchou, Sophie Molet, Patricia M. R. e Silva, Marco A. Martins, Elisabeth Boichot and Vincent LagenteJournal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 258-265; DOI: https://doi.org/10.1124/jpet.301.1.258
Geslin, Michel
- You have access4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological CharacterizationDanielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le FurJournal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
- You have access4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related DisordersGuy Griebel, Jacques Simiand, Régis Steinberg, Mireille Jung, Danielle Gully, Pierre Roger, Michel Geslin, Bernard Scatton, Jean-Pierre Maffrand and Philippe SoubriéJournal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 333-345; DOI: https://doi.org/10.1124/jpet.301.1.333
Giron-calle, Julio
- You have accessPriming of Alveolar Macrophage Respiratory Burst by H2O2 Is Prevented by Phosphatidylcholine-Specific Phospholipase C Inhibitor Tricyclodecan-9-yl-xanthate (D609)Julio Girón-Calle, Kousthub Srivatsa and Henry Jay FormanJournal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 87-94; DOI: https://doi.org/10.1124/jpet.301.1.87
Gordon, Adrienne S.
- You have accessEthanol Stimulates cAMP-Responsive Element (CRE)-Mediated Transcription via CRE-Binding Protein and cAMP-Dependent Protein KinaseOrna Asher, Thomas D. Cunningham, Lina Yao, Adrienne S. Gordon and Ivan DiamondJournal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 66-70; DOI: https://doi.org/10.1124/jpet.301.1.66
Gout, Georgette
- You have access4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological CharacterizationDanielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le FurJournal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
Griebel, Guy
- You have access4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological CharacterizationDanielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le FurJournal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
- You have access4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related DisordersGuy Griebel, Jacques Simiand, Régis Steinberg, Mireille Jung, Danielle Gully, Pierre Roger, Michel Geslin, Bernard Scatton, Jean-Pierre Maffrand and Philippe SoubriéJournal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 333-345; DOI: https://doi.org/10.1124/jpet.301.1.333
Grygielko, Eugene T.
- You have accessThe Angiotensin Type 1 Receptor Antagonist, Eprosartan, Attenuates the Progression of Renal Disease in Spontaneously Hypertensive Stroke-Prone Rats with Accelerated HypertensionChristian T. Abrahamsen, Frank C. Barone, Wallace G. Campbell, Allen H. Nelson, Lisa C. Contino, Mark A. Pullen, Eugene T. Grygielko, Richard M. Edwards, Nicholas J. Laping and David P. BrooksJournal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 21-28; DOI: https://doi.org/10.1124/jpet.301.1.21
Gudelsky, Gary A.
- You have access3,4-Methylenedioxymethamphetamine Produces Glycogenolysis and Increases the Extracellular Concentration of Glucose in the Rat BrainAltaf S. Darvesh, Mahalakshmi Shankaran and Gary A. GudelskyJournal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 138-144; DOI: https://doi.org/10.1124/jpet.301.1.138
Guitard, Josette
- You have access4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological CharacterizationDanielle Gully, Michel Geslin, Laurence Serva, Evelyne Fontaine, Pierre Roger, Christine Lair, Valerie Darre, Claudine Marcy, Pierre-Eric Rouby, Jacques Simiand, Josette Guitard, Georgette Gout, Regis Steinberg, Daniel Rodier, Guy Griebel, Philippe Soubrie, Marc Pascal, Rebecca Pruss, Bernard Scatton, Jean-Pierre Maffrand and Gerard Le FurJournal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 322-332; DOI: https://doi.org/10.1124/jpet.301.1.322
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 301, Issue 1
1 Apr 2002
Advertisement